You’re out of free articles.
Log in
To continue reading, log in to your account.
Create a Free Account
To unlock more free articles, please create a free account.
Sign In or Create an Account.
By continuing, you agree to the Terms of Service and acknowledge our Privacy Policy
Welcome to Heatmap
Thank you for registering with Heatmap. Climate change is one of the greatest challenges of our lives, a force reshaping our economy, our politics, and our culture. We hope to be your trusted, friendly, and insightful guide to that transformation. Please enjoy your free articles. You can check your profile here .
subscribe to get Unlimited access
Offer for a Heatmap News Unlimited Access subscription; please note that your subscription will renew automatically unless you cancel prior to renewal. Cancellation takes effect at the end of your current billing period. We will let you know in advance of any price changes. Taxes may apply. Offer terms are subject to change.
Subscribe to get unlimited Access
Hey, you are out of free articles but you are only a few clicks away from full access. Subscribe below and take advantage of our introductory offer.
subscribe to get Unlimited access
Offer for a Heatmap News Unlimited Access subscription; please note that your subscription will renew automatically unless you cancel prior to renewal. Cancellation takes effect at the end of your current billing period. We will let you know in advance of any price changes. Taxes may apply. Offer terms are subject to change.
Create Your Account
Please Enter Your Password
Forgot your password?
Please enter the email address you use for your account so we can send you a link to reset your password:
Plants are marching north. Native gardening will never be the same.

Thirteen miles isn’t very far: roughly the length of Manhattan or the distance you run in a half marathon. On a freeway, it takes less than 15 minutes to drive.
Multiply 13 by 10, though, and it becomes 130 miles — more than the width of the state of Connecticut. Move the U.S. border 130 miles north, and Whistler Blackcomb becomes an American ski resort; move it south, and Tijuana is the new Los Angeles. If you started walking, it would take you 35 straight hours to cover the distance; if you called an Uber, you’d be looking at a $450 ride.
The temperature regions that determine the local viability of different plants, called plant hardiness zones, are believed to be slipping north at a rate of about 13.3 miles per decade — not a number that sounds especially alarming, but one that will, over a century, add up to dramatically reshape the regional flora of the United States. In addition to being yet another depressing climate statistic, though, that number is also generating a lot of headaches in the surprisingly combustible world of native gardening.
It’s been 16 years (or approximately 21 northward miles) since Douglas Tallamy’s warning in his book Bringing Nature Home that “unless we restore native plants to our suburban ecosystems, the future of biodiversity in the United States is dim.” Though we may still be far from achieving his long-term goal of a “homegrown national park,” in which Americans convert half their yard space to native gardens, Tallamy’s teachings remain hugely influential in gardening and conservation circles (42 states have their own specialized native plant societies promoting these goals).
Tallamy insists that “all plants are not created equal, particularly in their ability to support wildlife.” If we’re to sustain the remaining biodiversity in the U.S., it is essential to feed insects — and in turn, the birds that eat those insects — the foods they’ve evolved to eat. If a plant isn’t native to these ecosystems, then it isn’t worth planting or sustaining. Often, says Tallamy, doing so is actively detrimental to biodiversity goals.
But what even is a native plant in this obviously shifting world? Already, New York City is considered subtropical, capable even of supporting certain hardy palms; by 2040, Seattle could be in the same hardiness zone that central Florida, New Orleans, and parts of Texas are in today. Researchers have seen plants native to the South slowly pushing their ranges north.
Native plants are frequently the species under the most stress from the new weather patterns in their historic ranges. The state tree of Washington, the Western hemlock, for example, is especially susceptible to drought and is struggling to survive in a drier Pacific Northwest. “We’ve found a lot of mortality of trees that should be in the prime in their life,” explained Raymond Larson, an associate director and curator at the University of Washington Botanic Gardens and a contributor to Great Plant Picks, a viability resource for Pacific Northwest gardeners.
As a result, many horticulturalists with an eye on the next century are actively exploring — and recommending — plants that are explicitly not native. Axios Seattle recently published a list of trees that Pete Smith, a program director at the Arbor Day Foundation, believes will be able to tolerate the next 50 to 100 years in the region, and it notably included the Japanese pagoda tree; the pawpaw, a native of the East Coast; and the ginkgo, which is “incredibly tough, very long-lived, and great at tolerating urban stresses” — but an exotic from China that is particularly reviled by Tallamy.
“What honestly most gardeners — many gardeners, anyway — have kind of lost track of is what the word ‘native’ means,” Smith explained to me when I followed up to ask about the globe-spanning range of his recommendations. “It is presumptuous, even, to talk about native plants as if 1492 was some magic date that talks about what is and was native to this continent.”
“Native” doesn’t have a hard and fast definition. In Bringing Nature Home, Tallamy writes that a true native is a plant that interacts “with the community that historically helped shape it,” but he also warns against using too small a timescale when making these determinations: “[A] history measured in centuries is the tiniest drop in the proverbial bucket of evolutionary time.” Native plant purists, Smith added, will argue that “the only quality tree is a tree that was grown from a seed from right underneath the tree that bore that seed. Isn’t that a wonderful ideal? [But] it’s not practical.”
Some native plant proponents have allowed for species that are retreating north (or up) on their own volition since these changes happen slowly and food-chain communities can relocate with them. A number of Southern species in the United States got there in the first place by being pushed down during the last ice age, and have been reclaiming prehistoric ranges as the cold has receded over the last 10,000 years. But ancient forests don’t appear to have migrated as complete ecosystems during these upheavals; it was a race of every-species-for-itself. “There’s a lot more interchangeability among members of an ecosystem than people had thought,” David Jablonski, a paleontologist, told the Smithsonian.
There is also the problem that the climactic zones are moving faster than trees can follow. “The average forest migrates at a rate of roughly 1,640 feet each year,” Wired has written — that is, about three miles in a decade. In order “to outrun climate change,” trees would need to book it north at a rate of “approximately 9,800 to 16,000 feet” a year, or about 10 times as fast. Plenty of foresters aren’t waiting around for that to happen and are seriously exploring the controversial idea of human-assisted migration.
Larson, at the UW Botanic Gardens, meanwhile, said their horticulturalists are looking off-continent for inspiration for the hard years ahead. “We’re experimenting more with plants in Mediterranean climates,” he said, and “also the southern hemisphere: Australia, Chile, New Zealand." Places that have "somewhat similar climates," to the Pacific Northwest, “but tend to get a little bit hotter." And while some of these experiments haven’t panned out as hoped in the past, “we’re going to try them again, because 5 or 10 degrees can make all the difference.”
The conventional wisdom, that introducing or nurturing exotics results in a decline in biodiversity, is also being challenged — often heatedly so. It can seem at times that for every study that expounds on the evils wrought by alien plants, another concludes the exact opposite. The ongoing debate has produced fiery polemics, such as one signed by 19 ecologists and published in Nature in 2011, which announced “it is time … to ditch this preoccupation with the native-alien dichotomy and embrace more dynamic and pragmatic approaches … better suited to our fast-changing planet.” The scientists also swatted down the frequent synonymizing of “nativeness” with “good,” pointing out that “the insect currently suspected to be killing more trees than any other in North America is the native mountain pine beetle.”
(These sorts of back-and-forths are presumably what led former Arnold Arboretum horticulturist Peter Del Tredici, one of the Nature letter’s signatories, to observe, “the use of exotic versus native species … seems to bring out the worst in people, not unlike the debates over gun control and abortion.” Whoever said gardening was boring?)
Arthur Shapiro, a distinguished professor of evolution and ecology at the University of California at Davis, is also among those who have challenged the uncompromising emphasis on the superiority of native plants. “There are many nonnative plants grown in gardens that are immensely useful to butterflies and other pollinators,” Shapiro told me. “And there are many native plants that are completely useless. They might as well be made with rubber or wood.” If you were to uproot every exotic plant in urban California, for instance, you’d “essentially do away with the butterfly fauna.”
That’s partially due to a principle known as ecological fitting, which is “what happens when species with totally disparate histories, that evolved in different parts of the world, come into contact — perhaps as a result of commerce, perhaps as a result of gardening — and they fit together,” said Shapiro. “It’s a marriage made in heaven.” Additionally, oft-vilified “novel ecosystems”, sometimes disparagingly dismissed as “trash ecosystems," arise when exotic species are naturalized due to human influence and/or certain native species recede. Increasingly, though, scientists like Shapiro are viewing these emerging anthropocenic systems as environmental success stories. An unmanaged invasive pine plantation in Puerto Rico, for example, was found to have far more biodiversity than a nearby native-only forest of the same age, Nature recounts; the observation, made in 1979, ran so counter to the established beliefs about the sanctity of native plants that “it took almost a decade" for the resulting paper to pass peer review.
The native/non-native dichotomy is undoubtedly clumsy, so much so that one idea has been to dispense with the unhelpful language altogether. “Neonative,” a term proposed by University of Vienna conservation biologist Franz Essl, for example, could be adapted to describe species that have moved beyond their native ranges and established new foothold populations “due to human-induced changes of the biophysical environment, but not as a result of direct movement by human agency.”
Another idea is to take a step back, put our preconceived notions in check, and learn from what we’re seeing. “As climate changes, communities are going to change, mixtures are going to change,” Shapiro said. “Trying to stop it — except for managing things of economic or medical importance, pests, or disease vectors — is equivalent to trying to plow the sea. It’s futile. So we should actually be paying close attention to what’s happening, because we can learn a lot from it, about how communities self-assemble.”
This isn’t your permission to go plant a bunch of English ivy and scotch broom, though. Two things can potentially both be true: certain native plants have essential ecological functions and some non-native plants can play an important role in shaping future ecosystems. In fact, they’re going to have to, if the climate keeps warming and the hardiness zones continue their upward march.
“We would always tell someone: choose native first,” Smith, of the Arbor Day Foundation, concurred. But at the same time, “Let’s not let the perfect be the enemy of the good.”
Log in
To continue reading, log in to your account.
Create a Free Account
To unlock more free articles, please create a free account.
The public-private project aims to help realize the president’s goal of building 10 new reactors by 2030.
The Department of Energy and the Westinghouse Electric Company have begun meeting with utilities and nuclear developers as part of a new project aimed at spurring the country’s largest buildout of new nuclear power plants in more than 30 years, according to two people who have been briefed on the plans.
The discussions suggest that the Trump administration’s ambitious plans to build a fleet of new nuclear reactors are moving forward at least in part through the Energy Department. President Trump set a goal last year of placing 10 new reactors under construction nationwide by 2030.
The project aims to purchase the parts for 8 gigawatts to 10 gigawatts of new nuclear reactors, the people said. The reactors would almost certainly be AP1000s, a third-generation reactor produced by Westinghouse capable of producing up to 1.1 gigawatts of electricity per unit.
The AP1000 is the only third-generation reactor successfully deployed in the United States. Two AP1000 reactors were completed — and powered on — at Plant Vogtle in eastern Georgia earlier this decade. Fifteen other units are operating or under construction worldwide.
Representatives from Westinghouse and the Energy Department did not respond to requests for comment.
The project would use government and private financing to buy advanced reactor equipment that requires particularly long lead times, the people said. It would seek to lower the cost of the reactors by placing what would essentially be a single bulk order for some of their parts, allowing Westinghouse to invest in and scale its production efforts. It could also speed up construction timelines for the plants themselves.
The department is in talks with four to five potential partners, including utilities, independent power producers, and nuclear development companies, about joining the project. Under the plan, these utilities or developers would agree to purchase parts for two new reactors each. The program would be handled in part by the department’s in-house bank, the Loan Programs Office, which the Trump administration has dubbed the Office of Energy Dominance Financing.
This fleet-based approach to nuclear construction has succeeded in the past. After the oil crisis struck France in the 1970s, the national government responded by planning more than three-dozen reactors in roughly a decade, allowing the country to build them quickly and at low cost. France still has some of the world’s lowest-carbon electricity.
By comparison, the United States has built three new nuclear reactors, totaling roughly 3.5 gigawatts of capacity, since the year 2000, and it has not significantly expanded its nuclear fleet since 1990. The Trump administration set a goal in May to quadruple total nuclear energy production — which stands at roughly 100 gigawatts today — to more than 400 gigawatts by the middle of the century.
The Trump administration and congressional Republicans have periodically announced plans to expand the nuclear fleet over the past year, although details on its projects have been scant.
Senator Dave McCormick, a Republican of Pennsylvania, announced at an energy summit last July that Westinghouse was moving forward with plans to build 10 new reactors nationwide by 2030.
In October, Commerce Secretary Howard Lutnick announced a new deal between the U.S. government, the private equity firm Brookfield Asset Management, and the uranium company Cameco to deploy $80 billion in new Westinghouse reactors across the United States. (A Brookfield subsidiary and Cameco have jointly owned Westinghouse since it went bankrupt in 2017 due to construction cost overruns.) Reuters reported last month that this deal aimed to satisfy the Trump administration’s 2030 goal.
While there have been other Republican attempts to expand the nuclear fleet over the years, rising electricity demand and the boom in artificial intelligence data centers have brought new focus to the issue. This time, Democratic politicians have announced their own plans to boost nuclear power in their states.
In January, New York Governor Kathy Hochul set a goal of building 4 gigawatts of new nuclear power plants in the Empire State.
In his State of the State address, Governor JB Pritzker of Illinois told lawmakers last week that he hopes to see at least 2 gigawatts of new nuclear power capacity operating in his state by 2033.
Meeting Trump’s nuclear ambitions has been a source of contention between federal agencies. Politico reported on Thursday that the Energy Department had spent months negotiating a nuclear strategy with Westinghouse last year when Lutnick inserted himself directly into negotiations with the company. Soon after, the Commerce Department issued an announcement for the $80 billion megadeal, which was big on hype but short on details.
The announcement threw a wrench in the Energy Department’s plans, but the agency now seems to have returned to the table. According to Politico, it is now also “engaging” with GE Hitachi, another provider of advanced nuclear reactors.
On nuclear tax credits, BLM controversy, and a fusion maverick’s fundraise
Current conditions: A third storm could dust New York City and the surrounding area with more snow • Floods and landslides have killed at least 25 people in Brazil’s southeastern state of Minas Gerais • A heat dome in Western Europe is pushing up temperatures in parts of Portugal, Spain, and France as high as 15 degrees Celsius above average.

The Department of Energy’s in-house lender, the Loan Programs Office — dubbed the Office of Energy Dominance Financing by the Trump administration — just gave out the largest loan in its history to Southern Company. The nearly $27 billion loan will “build or upgrade over 16 gigawatts of firm reliable power,” including 5 gigawatts of new gas generation, 6 gigawatts of uprates and license renewals for six different reactors, and more than 1,300 miles of transmission and grid enhancement projects. In total, the package will “deliver $7 billion in electricity cost savings” to millions of ratepayers in Georgia and Alabama by reducing the utility giant’s interest expenses by over $300 million per year. “These loans will not only lower energy costs but also create thousands of jobs and increase grid reliability for the people of Georgia and Alabama,” Secretary of Energy Chris Wright said in a statement.
Over in Utah, meanwhile, the state government is seeking the authority to speed up its own deployment of nuclear reactors as electricity demand surges in the desert state. In a letter to the Nuclear Regulatory Commission dated November 10 — but which E&E News published this week — Tim Davis, the executive director of Utah’s Department of Environmental Quality, requested that the federal agency consider granting the state the power to oversee uranium enrichment, microreactor licensing, fuel storage, and reprocessing on its own. All of those sectors fall under the NRC’s exclusive purview. At least one program at the NRC grants states limited regulatory primacy for some low-level radiological material. While there’s no precedent for a transfer of power as significant as what Utah is requesting, the current administration is upending norms at the NRC more than any other government since the agency’s founding in 1975.
Building a new nuclear plant on a previously undeveloped site is already a steep challenge in electricity markets such as New York, California, or the Midwest, which broke up monopoly utilities in the 1990s and created competitive auctions that make decade-long, multibillion-dollar reactors all but impossible to finance. A growing chorus argues, as Heatmap’s Matthew Zeitlin wrote, that these markets “are no longer working.” Even in markets with vertically-integrated power companies, the federal tax credits meant to spur construction of new reactors would make financing a greenfield plant is just as impossible, despite federal tax credits meant to spur construction of new reactors. That’s the conclusion of a new analysis by a trio of government finance researchers at the Center for Public Enterprise. The investment tax credit, “large as it is, cannot easily provide them with upfront construction-period support,” the report found. “The ITC is essential to nuclear project economics, but monetizing it during construction poses distinct challenges for nuclear developers that do not arise for renewable energy projects. Absent a public agency’s ability to leverage access to the elective payment of tax credits, it is challenging to see a path forward for attracting sufficient risk capital for a new nuclear project under the current circumstances.”
Steve Pearce, Trump’s pick to lead the Department of the Interior’s Bureau of Land Management, wavered when asked about his record of pushing to sell off federal lands during his nomination hearing Wednesday. A former Republican lawmaker from New Mexico, Pearce has faced what the public lands news site Public Domain called “broad backlash from environmental, conservation, and hunting groups for his record of working to undermine public land protections and push land sales as a way to reduce the federal deficit.” Faced with questions from Democratic senators, Pearce said, “I’m not so sure that I’ve changed,” but insisted he didn’t “believe that we’re going to go out and wholesale land from the federal government.” That has, however, been the plan since the start of the administration. As Heatmap’s Jeva Lange wrote last year, Republicans looked poised to use their trifecta to sell off some of the approximately 640 million acres of land the federal government owns.
Sign up to receive Heatmap AM in your inbox every morning:
At Tuesday’s State of the Union address, as I told you yesterday, Trump vowed to force major data center companies to build, bring, or buy their own power plants to keep the artificial intelligence boom from driving up electricity prices. On Wednesday, Fox News reported that Amazon, Google, Meta, Microsoft, xAI, Oracle, and OpenAI planned to come to the White House to sign onto the deal. The meeting is set to take place sometime next month. Data centers are facing mounting backlash. Developers abandoned at least 25 data centers last year amid mounting pushback from local opponents, Heatmap's Robinson Meyer recently reported.
Shine Technologies is a rare fusion company that’s actually making money today. That’s because the Wisconsin-based firm uses its plasma beam fusion technology to produce isotopes for testing and medical therapies. Next, the company plans to start recycling nuclear waste for fresh reactor fuel. To get there, Shine Technologies has raised $240 million to fund its efforts for the next few years, as I reported this morning in an exclusive for Heatmap. Nearly 63% of the funding came from biotech billionaire Patrick Soon-Shiong, who will join the board. The capital will carry the company through the launch of the world’s largest medical isotope producer and lay the foundations of a new business recycling nuclear waste in the early 2030s that essentially just reorders its existing assembly line.
Vineyard Wind is nearly complete. As of Wednesday, 60 of the project’s 62 turbines have been installed off the coast of Massachusetts. Of those, E&E News reported, 52 have been cleared to start producing power. The developer Iberdrola said the final two turbines may be installed in the next few days. “For me, as an engineer, the farm is already completed,” Iberdrola’s executive chair, Ignacio Sánchez Galán, told analysts on an earnings call. “I think these numbers mean the level of availability is similar for other offshore wind farms we have in operation. So for me, that is completed.”
That doesn’t mean it plans to produce electricity anytime soon.
Greg Piefer thinks nearly all his rivals in the race to commercialize fusion are doing it backward.
Of the 59 companies tracked in the Fusion Industry Association’s latest annual survey, 48 are primarily focused on generating electricity, off-grid energy, or industrial heat by harnessing the power produced when two atoms fuse together in the same type of reaction that fuels the sun. Just four are following the path of Shine Technologies and using plasma beam energy to manufacture rare and extremely valuable radioisotopes for breakthrough cancer treatments — 10 if you count the startups with a secondary medical business.
“We’re a bit different from fusion companies trying to sell the single product of electricity,” Piefer, the chief executive of Wisconsin-based Shine Technologies, told me. “The basic premise of our business is fusion is expensive today, so we’re starting by selling it to the highest-paying customers first.”
Shine Technologies’ contrarian strategy is winning over investors. On Thursday, the company plans to announce a $240 million Series E round, Heatmap can report exclusively. The funding, nearly 63% of which came from biotech billionaire Patrick Soon-Shiong, will provide enough capital to carry the company to the launch of the world’s largest medical isotope producer and lay the foundations of a new business recycling nuclear waste.
For now, Piefer said, Shine’s business is blasting uranium with enough extremely hot plasma beam energy to generate medical isotopes such as molybdenum-99 for diagnostic imaging or lutetium-177 for targeted cancer therapies. In the next few years, however, Shine Technologies is looking to apply its methods to recycling and reducing radioactive waste from commercial fission reactors’ spent fuel. Only then, sometime a decade from now, will the company start working on power plants.
“I would essentially define electricity as the lowest-paying customer of significance for fusion today,” Piefer said.
Soon-Shiong contributed $150 million to the funding pool via NantWorks, the biotech company he founded. Other investors include the financial services giant Fidelity Investments, the American division of the Japanese industrial conglomerate Sumitomo Corporation, the Texas investment bank Pelican Energy Partners, the healthcare-focused investor Deerfield Management, and the global asset manager Oaktree Capital. As part of the deal, Soon-Shiong — known outside the medical industry as the owner of the Los Angeles Times — will join Shine Technologies’ board of directors.
Since its founding in 2005, Shine has brought down the cost per fusion reaction by a thousandsfold. Over a Zoom call, Piefer pointed out the window behind him in his office in Janesville, Wisconsin, nearly two hours southwest of Milwaukee. In the afternoon sun was a gray, nondescript-looking warehouse. Inside, construction was underway on the world’s largest facility for producing medical isotopes. Dubbed Chrysalis, the flagship plant is set to come online in 2028.
“We’ll make 20 million doses of medicine per year with it,” he said. “It’ll be the biggest beneficial use of fusion for humans ever, and we expect it to be the dominant technology for decades. This will be the way the United States produces neutron-based radioisotopes probably for the next 50 years.”
To make medicine, the company follows four steps. First, it dissolves uranium. Next, it irradiates the material with the plasma beam. Then comes the separation process to remove valuable isotopes from the other radioactive material. Finally leftover uranium gets recycled back into the process. Rinse and repeat.
“It’s the first closed loop ever used for producing medicine this way,” Piefer said.
To recycle spent nuclear fuel, the company just remixes those steps, he said.
“You dissolve uranium from the nuclear waste. You separate out valuable materials. You recycle the uranium and plutonium in a reactor,” Piefer said. Then fusion comes in with the plasma beam technology to transform highly radioactive material that stays dangerous for longer than Homo sapiens is known to have existed into something that decays in half-lives that take years, decades, or centuries rather than millennia, decamillennia, and centimillennia.
“There’s about half a percent of long-lived nuclear waste from fission that we don’t know what to do with. It lives basically forever. We don’t have a use for it. But if you hit it with fusion neutrons, it becomes short-lived,” Piefer said. “So it’s the same four steps. For medicine, it goes one, two, three, four. For recycling it goes one, three, four, two.”
Not only is the market for testing and medical isotopes already worth billions of dollars, it’s on track to more than double in the next decade. Currently, it’s largely served by what Piefer called “60-year-old fission reactors.”
“These are specialized research reactors that are very cold and very constrained from a capacity standpoint,” he said. “You can buy new ones, but it takes billions of dollars and probably two decades to bring a new reactor online.”
By contrast, Shine Technologies broke ground on Chrysalis in 2019, and is set to complete the project at what Piefer said would be an eighth the cost of building a new research reactor.
The U.S. government, meanwhile, is helping to fund the next phase of Shine Technologies’ business. Just a few weeks ago, the Department of Energy gave the company a share of $19 million split between five companies looking to commercialize reprocessing technology. Last year, the company inked a deal with the reactor fuel startup Standard Nuclear to sell the fuel-grade material it recovers from recycling.
In both the fusion and next-generation fission industries, companies often lure investors by promising to pull off several very challenging things at once, said Chris Gadomski, the lead nuclear analyst at the consultancy BloombergNEF.
Oklo, a stock market darling for its planned microreactor and power plant business, was also among the recipients of the federal funding for waste reprocessing. Amazon-backed microreactor developer X-energy just won approval to start manufacturing the rare and expensive form of reactor fuel known as TRISO. TAE Technologies, the fusion startup that merged in December with the parent company of President Donald Trump’s social media network TruthSocial in a bid to build the world’s first fusion power plant, also has a subsidiary producing medical isotopes.
“I usually look at it as a distressing sign when you have an energy company tackling four or five different things,” Gadomski said. “But Shine is really a medical device company that is focused on isotopes but whose technology can also reprocess spent fuel — and, by the way, it can be applied down the road to energy.”
So far, Shine’s technology has followed a similar Moore’s Law trajectory to semiconductors.
From roughly 1990 to 2000, microchips used in workstations increased their computation rate per dollar. Then came the gaming era from 2000 to 2015, when videogames drove demand for more and more efficient semiconductors, with upgrades on average every other year. From 2015 until roughly the debut of ChatGPT in 2022, the high-speed computing applications spurred on chip upgrades at a similar rate. Now the artificial intelligence era is upon us, transforming chipmakers such as Nvidia into goliaths seemingly overnight.
Piefer sees Shine Technologies on its own 35-year timeline. From 2010 to roughly 2023, testing dominated the business. From then until about 2028, medical isotopes are the new play. The recycling pilot plant set to come online after 2030 will kick off the reprocessing period. And finally, sometime in the 2040s, Piefer wants to get into energy production.
“It’s a different approach than most,” he said.
“Don’t get me wrong, moonshots have their place, too,” he added. “But I feel very confident in this path.”